Design Therapeutics, Inc. has been removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.42 USD | +7.21% |
|
+2.09% | +29.06% |
Jun. 17 | Design Therapeutics, Inc. Elects Pratik Shah, Ph.D. as Class III Director | CI |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.06% | 193M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Design Therapeutics, Inc.(NasdaqGS: DSGN) dropped from NASDAQ Biotechnology Index